Impact of Driver Mutations in NSCLC

Skip Ad in 6 Seconds

Browse Other Featured Videos

RET inhibition in RET aberrant cancers

July 10th, 2019    124 Views

Clinical Trial to Treat Gliosarcoma or Primary CNS Sarcoma

April 10th, 2020    22 Views

Gene Inhibitors in Cancer

JAK-Inhibition in Immune-Mediated Diseases (IMiDs)

July 25th, 2019    1247 Views

Nrf2 inhibitors to overcome chemoresistance

July 22nd, 2019    374 Views

Featured Videos from Sponsors

FFPE Slide Optimization Tips & Tricks

February 28th, 2020    289 Views

Bone Marrow & Blood Protocol Optimization Tips

March 19th, 2020    326 Views

Research in Diagnostic and Treatment Techniques

Fixed-duration therapy with venetoclax-obinutuzumab in frontline CLL

June 14th, 2019    466 Views

M-protein diagnostics of Multiple Myeloma patients treated with biologics

April 1st, 2018    1743 Views

Inspiring Discussions on Cytogenetics

Is the Study of Monogenic Diseases of the Immune System Relevant?

March 8th, 2020    575 Views

IPPCR: Developing Protocols and Manuals of Operating Procedures

March 12th, 2020    4204 Views

Gene Mutation and Gene Fusion Research

Biomarkers Evolve for Treatment of Lung Cancers

February 24th, 2020    81 Views

Dr. Gubens Discusses the Role of PD-L1 in Patients With NSCLC

March 21st, 2019    133 Views

New Disease Research

Risk stratification in metastatic seminoma

March 3rd, 2020    70 Views

Lynch Syndrome and Less Common Cancers | Dana-Farber Cancer Institute

July 16th, 2019    253 Views